Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Identification of a plausible serum uric acid cut-off value as prognostic marker of stroke: the Uric Acid Right for Heart Health (URRAH) study

Abstract

The Working Group on Uric Acid and Cardiovascular Risk of the Italian Society of Hypertension conceived and designed an ad hoc study aimed at searching for prognostic cut-off values of serum uric acid (SUA) in predicting combined (fatal and non-fatal) cerebrovascular (CBV) events in the whole database. The URic acid Right for heArt Health study is a nationwide, multicenter, observational cohort study involving data on subjects aged 18–95 years recruited on a regional community basis from all the territory of Italy under the patronage of the Italian Society of Hypertension with a mean follow-up period of 120.7 ± 61.8 months. A total of 14,588 subjects were included in the analysis. A prognostic cut-off value of SUA able to discriminate combined CBV events (>4.79 mg/dL or >284.91 µmol/L) was identified by means of receiver operating characteristic curve in the whole database. Multivariate Cox regression analysis adjusted for confounders (age, sex, arterial hypertension, diabetes, chronic kidney disease, smoking habit, ethanol intake, body mass index, low-density lipoprotein cholesterol, and use of diuretics) identified an independent association between SUA and combined CBV events in the whole database (HR 1.249, 95% confidence interval, 1.041–1.497, p = 0.016). The results of the present study confirm that SUA is an independent risk marker for CBV events after adjusting for potential confounding variables, including arterial hypertension, and demonstrate that >4.79 mg/dL is a valid prognostic cut-off value.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Receiver-operator-characteristic (ROC) curves of combined cerebrovascular events.
Fig. 2: Kaplan–Meier curves of survival probability for combined cerebrovascular events in the overall population.
Fig. 3: Adjusted hazard ratios with 95% confidence intervals of the combined cerebrovascular events for having serum uric acid >4.79 mg/dL by quintiles of age in models including the interaction term cut-off value of SUA × age and other covariates.

Similar content being viewed by others

References

  1. Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med. 1999;131:7–13.

    Article  CAS  PubMed  Google Scholar 

  2. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA. 2000;283:2404–10.

    Article  CAS  PubMed  Google Scholar 

  3. Rahimi-Sakak F, Maroofi M, Rahmani J, Bellissimo N, Hekmatdoost A. Serum uric acid and risk of cardiovascular mortality: a systematic review and dose-response meta-analysis of cohort studies of over a million participants. BMC Cardiovasc Disord. 2019;19:218.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Odden MC, Amadu AR, Smit E, Lo L, Peralta CA. Uric acid levels, kidney function, and cardiovascular mortality in US adults: National Health and Nutrition Examination Survey (NHANES) 1988–1994 and 1999–2002. Am J Kidney Dis. 2014;64:550–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Bos MJ, Koudstaal PJ, Hofman A, Witteman JC, Breteler MM. Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study. Stroke. 2006;37:1503–7.

    Article  CAS  PubMed  Google Scholar 

  6. Becker BF. Towards the physiological function of uric acid. Free Radic Biol Med. 1993;14:615e31.

    Article  Google Scholar 

  7. Nieto FJ, Iribarren C, Gross MD, Comstock GW, Cutler RG. Uric acid and serum antioxidant capacity: a reaction to atherosclerosis. Atherosclerosis. 2000;148:131e9.

    Article  Google Scholar 

  8. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest. 1994;94:1172e9.

    Article  Google Scholar 

  9. Li M, Hou W, Zhang X, Hu L, Tang Z. Hyperuricemia and risk of stroke: a systematic review and meta-analysis of prospective studies. Atherosclerosis. 2014;232:265–70.

    Article  CAS  PubMed  Google Scholar 

  10. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and risk of stroke: a systematic review and meta-analysis. Arthritis Rheum. 2009;61:885–92.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Desideri G, Virdis A, Casiglia E, Borghi C. Exploration into uric and cardiovascular disease: Uric Acid Right for heArt Health (URRAH) Project. A study protocol for a retrospective observational study. High Blood Press Cardiovasc Prev. 2018;25:197–202.

    Article  CAS  PubMed  Google Scholar 

  12. Casiglia E, Tikhonoff V, Virdis A, Masi S, Barbagallo CM, Bombelli M, et al. Serum uric acid and fatal myocardial infarction: detection of prognostic cut-off values: The URRAH (Uric Acid Right for Heart Health) study. J Hypertens. 2020;38:412–9.

    Article  CAS  PubMed  Google Scholar 

  13. Virdis A, Masi S, Casiglia E, Tikhonoff V, Cicero AFG, Ungar A, et al. Identification of the uric acid thresholds predicting an increased total and cardiovascular mortality over 20 years. Hypertension. 2020;75:302–8.

    Article  CAS  PubMed  Google Scholar 

  14. Muiesan ML, Salvetti M, Virdis A, Masi S, Casiglia E, Tikhonoff V, et al. Serum uric acid predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study. J Hypertens. 2021;39:62–9.

    Article  CAS  PubMed  Google Scholar 

  15. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–12.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Casiglia E, Palatini P. Cardiovascular risk factors in the elderly. J Hum Hypertens. 1998;12:575–81.

    Article  CAS  PubMed  Google Scholar 

  17. Casiglia E, Spolaore P, Ginocchio G, Colangeli G, Di Menza G, Marchioro M, et al. Predictors of mortality in very old subjects aged 80 years or over. Eur J Epidemiol. 1993;9:577–86.

    Article  CAS  PubMed  Google Scholar 

  18. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837–45.

    Article  CAS  PubMed  Google Scholar 

  19. Kamarudin AN, Cox T, Kolamunnage-Dona R, Time-dependent ROC. curve analysis in medical research: current methods and applications. BMC Med Res Methodol. 2017;17:53.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3:32–5.

    Article  CAS  PubMed  Google Scholar 

  21. Schisterman EF, Perkins NJ, Liu A, Bondell H. Optimal cut-point and its corresponding Youden index to discriminate individuals using pooled blood samples. Epidemiology. 2005;16:73–81.

    Article  PubMed  Google Scholar 

  22. Mazza A, Zamboni S, Tikhonoff V, Schiavon L, Pessina AC, Casiglia E. Body mass index and mortality in elderly men and women from general population. Gerontology. 2007;53:36–45.

    Article  PubMed  Google Scholar 

  23. Maloberti A, Bombelli M, Facchetti R, Desideri G, Cicero AFG, Muiesan ML, et al. Relationships between diuretic-related hyperuricemia and cardiovascular events: data from the URRAH (URic acid Right for heArt Health) study. J Hypertens. 2021;39:333–40.

  24. Alderman MH, Cohen H, Madhavan S, Kivlighn S. Serum uric acid and cardiovascular events in successfully treated hypertensive patients. Hypertension. 1999;34:144–50.

    Article  CAS  PubMed  Google Scholar 

  25. Casiglia E, Mazza A, Tikhonoff V, Pavei A, Privato G, Schenal N, et al. Weak effect of hypertension and other classic risk factors in the elderly who have already paid their toll. J Hum Hypertens. 2002;16:21–31.

    Article  CAS  PubMed  Google Scholar 

  26. Zhong C, Zhong X, Xu T, Xu T, Zhang Y. Sex‐specific relationship between serum uric acid and risk of stroke: a dose‐response meta‐analysis of prospective studies. J Am Heart Assoc. 2017;6:pii:e005042.

    Article  Google Scholar 

  27. Ruoff G, Edwards NL. Overview of serum uric acid treatment targets in gout: why less than 6 mg/dl? Postgrad Med. 2016;128:706–15.

    Article  PubMed  Google Scholar 

  28. Khanna D, Fitzgerald JD, Khanna PP, Bae S, Singh MK, Neogi T, et al. 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res. 2012;64:1431–46.

    Article  CAS  Google Scholar 

  29. Storhaug HM, Norvik JV, Toft I, Eriksen BO, Løchen ML, Zykova S, et al. Uric acid is a risk factor for ischemic stroke and all-cause mortality in the general population: a gender specific analysis from The Tromsø Study. BMC Cardiovasc Disord. 2013;13:115.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Xu Y, Zhu J, Gao L, Liu Y, Shen J, Shen C, et al. Hyperuricemia as an independent predictor of vascular complications and mortality in type 2 diabetes patients: a meta-analysis. PLoS One. 2013;8:e78206.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Du L, Ma J, Zhang X. Higher serum uric acid may contribute to cerebral infarction in patients with type 2 diabetes mellitus: a meta-analysis. J Mol Neurosci. 2017;61:25–31.

    Article  CAS  PubMed  Google Scholar 

  32. Burnier M, Bakris G, Williams B. Redefining diuretics use in hypertension: why select a thiazide-like diuretic? J Hypertens. 2019;37:1574–86.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Jin M, Yang F, Yang I, Yin Y, Luo JJ, Wang H, et al. Uric acid, hyperuricemia and vascular diseases. Front Biosci. 2012;17:656–69.

    Article  CAS  PubMed Central  Google Scholar 

  34. Suarna C, Dean RT, May J, Stocker R. Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of alpha–tocopherol and ascorbate. Arterioscler Thromb Vasc Biol. 1995;15:1616–24.

    Article  CAS  PubMed  Google Scholar 

  35. Visy JM, LeCoz P, Chadefaux B, Fressinaud C, Woimant F, Marquet J, et al. Homocystinuria due to 5,10–methylenetetrahydrofolate reductase deficiency revealed by stroke in adult siblings. Neurology. 1991;41:1313–5.

    Article  CAS  PubMed  Google Scholar 

  36. Kanbay M, Segal M, Afsar B, Kang DH, Rodriguez-Iturbe B, Johnson RJ. The role of uric acid in the pathogenesis of human cardiovascular disease. Heart. 2013;99:759–66.

    Article  CAS  PubMed  Google Scholar 

  37. De Scheeder IK, van de Kraay AM, Lamers JM, Koster JF, deJong JW, Serruys PW. Myocardial malondialdehyde and uric acid release after short-lasting coronary occlusions during angioplasty: potential mechanisms for free radical generation. Am J Cardiol. 1991;68:392–5.

    Article  Google Scholar 

  38. Tikhonoff V, Kuznetsova T, Stolarz K, Bianchi G, Casiglia E, Kawecka-Jaszcz K, et al. β-adducin polymorphism, blood pressure, and sodium excretion in three European populations. Am J Hypert. 2003;16:840–6.

    Article  CAS  Google Scholar 

Download references

Funding

This work has been conducted with an unrestricted grant from the Fondazione of the Italian Society of Hypertension (grant: MIOL).

Author information

Authors and Affiliations

Authors

Consortia

Contributions

Conception and design: VT, EC. Acquisition of data: VT, EC, PS, CMB, MB, AFGC, MC, PC, GD, LD, CF, FG, LG, CG, GI, FM, AM, SM, AM, MLM, PN, PP, GP, RP, FQ-T, MR, GR, MS, GT, AU, PV, FV, AV, MV, GG, CB. Analysis and interpretation of data: VT, EC. Drafting of the manuscript or revising it critically for important intellectual content: VT, EC, GB, CF, FG, CG, FM, MLM, PP, GP, RP, AU, PV, AV, MV, GG, CB. Final approval of the manuscript submitted: VT, EC, PS, CMB, MB, AFGC, MC, PC, GD, LD, CF, FG, LG, CG, GI, FM, AM, SM, AM, MLM, PN, PP, GP, RP, FQ-T, MR, GR, MS, GT, AU, PV, FV, AV, MV, GG, GB.

Corresponding author

Correspondence to Valérie Tikhonoff.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tikhonoff, V., Casiglia, E., Spinella, P. et al. Identification of a plausible serum uric acid cut-off value as prognostic marker of stroke: the Uric Acid Right for Heart Health (URRAH) study. J Hum Hypertens 36, 976–982 (2022). https://doi.org/10.1038/s41371-021-00613-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41371-021-00613-5

This article is cited by

Search

Quick links